A new study, led by Professor John Deanfield from University College London (UCL), reveals that the anti-obesity medication ...

Renoprotective Effects of Metabolic Surgery Versus GLP1 Receptor Agonists on Progression of Kidney Impairment in Patients ...

Why fork over thousands of dollars a month for prescription weight loss jabs when store-bought supplements claim to have the ...

Few medications have become as popular and culturally relevant as Ozempic has, but how exactly do it and similar drugs affect ...

Pemvidutide's potential in obesity and MASH, combined with lean mass preservation, could make it a market leader in the ...

The new Lemme GLP-1 Daily Capsules are being called an "Ozempic alternative." But do they really work — and if so, at what ...

Patients prescribed glucagon-like peptide-1 agonists, including Ozepmic and Wegovy, have a significantly higher postoperative infection rate following ankle-fusion procedures, according to a Sept. 20 ...

Akero Therapeutics has a solid cash runway and financial stability to support ongoing trials for its drug candidate. Read ...

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery ...

Weight loss injections are essentially the opposite of pills in terms of pros and cons. They’re generally more effective and ...

Bariatric surgery was shown to protect kidney function and reduce the risk of kidney failure in study participants when compared to GLP-1 ...

but they do not contain GLP-1. They do not contain an agonist or a mimicking hormone,” Raj said in a TODAY segment that aired on Thursday, Sept. 19. “They contain extracts, maybe from fruits or ...